3-126608543-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052883.3(TXNRD3):c.1819C>A(p.Gln607Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,383,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_052883.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNRD3 | NM_052883.3 | c.1819C>A | p.Gln607Lys | missense_variant | 15/16 | ENST00000524230.9 | NP_443115.1 | |
TXNRD3 | NM_001173513.3 | c.1711C>A | p.Gln571Lys | missense_variant | 14/15 | NP_001166984.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNRD3 | ENST00000524230.9 | c.1819C>A | p.Gln607Lys | missense_variant | 15/16 | 1 | NM_052883.3 | ENSP00000430031.4 | ||
TXNRD3 | ENST00000383572.3 | n.13C>A | non_coding_transcript_exon_variant | 1/4 | 1 | |||||
TXNRD3 | ENST00000523403.3 | c.1711C>A | p.Gln571Lys | missense_variant | 14/15 | 2 | ENSP00000429584.3 | |||
TXNRD3 | ENST00000518740.5 | n.196C>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000143 AC: 2AN: 139436Hom.: 0 AF XY: 0.0000132 AC XY: 1AN XY: 75552
GnomAD4 exome AF: 0.0000130 AC: 18AN: 1383702Hom.: 0 Cov.: 30 AF XY: 0.0000161 AC XY: 11AN XY: 682792
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2024 | The c.1819C>A (p.Q607K) alteration is located in exon 15 (coding exon 15) of the TXNRD3 gene. This alteration results from a C to A substitution at nucleotide position 1819, causing the glutamine (Q) at amino acid position 607 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at